6505NCM252124: INFLUENZA VIRUS VACCINE.
The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, part_name_assigned_by_controlling_agency: INFLUENZA VIRUS VACCINE, USP, FLUZONE; 2026-2027 FORMULA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-735-0234, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| part_name_assigned_by_controlling_agency | INFLUENZA VIRUS VACCINE, USP, FLUZONE; 2026-2027 FORMULA |
| NSN | 6505-01-735-0234 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | INFLUENZA VIRUS VACCINE, USP, TRIVALENT MULTI DOSE VIAL; 10 DOSE MDV; FOR FLU SEASON 2026-2027; FOR IMMUNIZING PERSONS 6 MONTHS AND OLDER; CONTAINS PRESERVATIVE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG C;DO NOT FREEEZE DEGC |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INFLUENZA VIRUS VACCINE, USP, FLUZONE; 2026-2027 FORMULA |